key: cord-0967342-mlabjag9
authors: Parry, Arshed Hussain; Wani, Abdul Haseeb
title: Pulmonary embolism in coronavirus disease-19 (COVID-19) and use of compression ultrasonography in its optimal management
date: 2020-05-16
journal: Thromb Res
DOI: 10.1016/j.thromres.2020.05.022
sha: 2d1dddf25779f5e156f5d985d03ad2f0f32ef0bc
doc_id: 967342
cord_uid: mlabjag9

nan

Additionally, it also involves use of contrast media which might be contraindicated in patients with severe COVID-19 with associated deranged renal function or patients with contrast allergy.

On the other hand compression ultrasound is a bedside modality with advantages of wide availability, rapidity and safety (no need of contrast media and lack of radiation exposure).

Patients with positive compression ultrasound can be started on anticoagulants without further need of CTA. According to the PIOPED II this group of PE patients may be as high as 50-70%

(4). However, patients with a negative compression ultrasound with suspicion of PE should be subjected to further testing in the form of CTA. This approach is logistically easy, rapid, widely available, inexpensive and safe.

Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography

Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography